Syneron Medical Ltd (ELOS) Tops Q3 EPS by 3c

November 9, 2016 7:54 AM EST
Get Alerts ELOS Hot Sheet
Trade ELOS Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Syneron Medical Ltd (Nasdaq: ELOS) reported Q3 EPS of $0.08, $0.03 better than the analyst estimate of $0.05. Revenue for the quarter came in at $71.5 million versus the consensus estimate of $68.08 million.

As of September 30, 2016, the Company's overall cash position, including cash and cash equivalents, short-term bank deposits and marketable securities, grew to $82.9 million from $76.7 million as of June 30, 2016.

For earnings history and earnings-related data on Syneron Medical Ltd (ELOS) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment